Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Boston Scientific Corp shares valued at $5,799,630 were sold by Fitzgerald Joseph Michael on Jun 04 ’25. At $102.88 per share, Fitzgerald Joseph Michael sold 56,372 shares. The insider’s holdings dropped to 178,342 shares worth approximately $17.73 million following the completion of this transaction.
Also, JOSEPH M FITZGERALD purchased 56,372 shares, netting a total of over 5,799,625 in proceeds.
Before that, Mahoney Michael F had sold 164,443 shares from its account. In a trade valued at $17,051,136, the Chairman, President & CEO traded Boston Scientific Corp shares for $103.69 each. Upon closing the transaction, the insider’s holdings decreased to 164,443 shares, worth approximately $146.8 million.
As published in a research note from Needham on April 16, 2025, Boston Scientific Corp [BSX] has been rated up from a Hold to a Buy and the price target has been revised to $113. Analysts at Deutsche Bank upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early January. As of October 18, 2024, Needham has decreased its “Buy” rating to a “Hold” for BSX. Earlier on May 30, 2024, Goldman initiated its rating. Their recommendation was “a Buy” for BSX stock.
Analyzing BSX Stock Performance
During the last five days, there has been a drop of approximately -2.96%. Over the course of the year, Boston Scientific Corp shares have jumped approximately 11.29%. Shares of the company reached a 52-week high of $107.17 on 02/05/25 and a 52-week low of $85.98 on 04/07/25.
Support And Resistance Levels for Boston Scientific Corp (BSX)
According to the 24-hour chart, there is a support level at 98.76, which, if violated, would cause prices to drop to 98.12. In the upper region, resistance lies at 100.06. The next price resistance is at 100.72. RSI (Relative Strength Index) is 36.33 on the 14-day chart, showing neutral technical sentiment.
